Hjem › Mesoteliom › Pennsylvania
Mesoteliom kliniske forsøg i Pennsylvania
13 studier for Mesoteliom søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07277413A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Allegheny Health Network (Data Collection Only), Pittsburgh
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06057935Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT06566079A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
- AHN West Penn Hospital, Pittsburgh
RekruttererFase 1
Alder 18 til 79 · Alle køn · Opdateret 4. aug. 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Pittsburgh Medical Center, Pittsburgh
RekruttererFase 1/2
Alder 18 til 90 · Alle køn · Opdateret 6. jul. 2026 · NCT06710756SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- University of Pennsylvania, Philadelphia
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06756035A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 7. apr. 2026 · NCT06444815Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
- AHN West Penn Hospital, Pittsburgh
RekruttererFase 1
Alder 18 til 79 · Alle køn · Opdateret 7. apr. 2026 · NCT07443020VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
RekruttererFase 1/2
Alder 18 til 80 · Alle køn · Opdateret 11. dec. 2025 · NCT03556228Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. dec. 2025 · NCT03760575Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.